Moving forwards, said Dr Mighell, colleagues would be able to seek confirmation of a suspected diagnosis of AI which could identify the relevant genetic mutation. They would be able to find out whether they might be at risk of other health issues, such as renal calcification.
He described the role of nanotomography in visualising enamel affected by AI. 'Even the scrappiest bit of tooth can be phenomenally revealing of the underlying phenotype. ' Dr Mighell's talk was one of several in an entire session dedicated to AI, during which it emerged that this cohort of patients would be well served by greater clarity around their diagnosis.
The eminent paediatric dentist Kathy Harley, a speaker in the same session, in which she shared her restorative approach for young people with AI, later paid tribute to the 'fabulous work' that is taking place in Leeds. 'The whole genetic evolution is so exciting because ultimately we may be able to identify AI patients at birth and, over time, with differing interventions, these patients will need less and less treatment. ' However, the path to routine genetic testing for AI is not necessarily smooth. There are some considerations. Firstly, the fact that the test cannot deliver all the answers a family might want. Given that all the genes that cause AI are not yet known, the NHS test could simply be returned as negative and other avenues would need to be explored.
Then there is the cost to the NHS -£860 per test. As with many actuarial decisions, the fee which would potentially yield a diagnosis and an early treatment plan and inform improved care pales into insignificance when weighed up against the current cost of managing a young child with the condition where GA and long-term restorative costs are the norm. What's not clear is how many specialist dentists will want to request genetic testing. Suzanne Scott, senior lecturer in health psychology at King's College London Dental Institute, explained that gaining informed consent for a genetic test is essential, yet complex. There is research showing that patients who are not fully informed about the test or the implications of genetic testing can be more distressed by the result.
She said there is a considerable amount of guidance on the issue. It was important that the professionals have been appropriately trained in offering a genetic test while patients and their families need to be sufficiently supported when they receive the result.
'You need to be careful that if there is going to be a referral, it should happen early on -it should not be a last resort. And there should be clear criteria for referral. When you are dealing with genetics there are issues around family dynamics and there may be feelings of guilt or shame around passing on a condition. ' Ater the availability of a genetic test was announced at the BSPD conference, members of BSPD were invited to participate in focus groups to share their views. It's anticipated their feedback will help inform the transition to a routine use of the test. In the coming months, if you think a patient of yours has amelogenesis imperfecta (AI) then genetic testing can be requested via a specialist in paediatric dentistry.
Said Dr Mighell: 'We are in the middle of a genetics revolution because we can sequence people's DNA at a previously unimaginable rate and at relatively low cost and computers can handle and sort through the mass of data that this generates. Genetics is going to move to the forefront of healthcare in this and many other areas. ' Even bigger developments are on the horizon. Already, a new drug trial has found it's possible to switch off some AI genes in mice. Dr Mighell added: 'This may be possible in humans sooner than you might think. ' 
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